|Articles|September 1, 2001

September 2001
Volume 7
Issue 9

Comparison of Prevalence, Cost, and Outcomes of a Combination of Salmeterol and Fluticasone Therapy to Common Asthma Treatments

Author(s)Stephanie W. Wang, PhD, Xiaofeng Liu, MD, PhD, Douglas J. Weiner, MD

Download PDF: Comparison of Prevalence, Cost, and Outcomes of a Combination of Salmeterol and Fluticasone Therapy to Common Asthma Treatments

Articles in this issue

over 24 years ago

Article

A Benefit-Based Copay for Prescription Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost

over 24 years ago

Article

Effect of Moderate Weight Loss on Health-Related Quality of Life: An Analysis of Combined Data From 4 Randomized Trials of Sibutramine vs Placebo

over 24 years ago

Article

A Randomized Intervention to Improve Ongoing Participation in Mammography

over 24 years ago

Article

Impact of a Targeted Asthma Intervention Program on Treatment Costs in Patients with Asthma

over 24 years ago

Article

Weight Loss and Health-Related Quality of Life

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

On-Demand Virtual Symposium

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

On-Demand Virtual Symposium

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

Comparison of Prevalence, Cost, and Outcomes of a Combination of Salmeterol and Fluticasone Therapy to Common Asthma Treatments

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Trending on AJMC

MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS

TrumpRx Launch Brings Savings—and Uncertainty

Intraarterial Alteplase After Thrombectomy May Improve Stroke Recovery: CHOICE2

Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP

Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial